Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All exercise studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchExerciseExercise (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Severe case 81% Improvement Relative Risk Hospitalization 56% Exercise for COVID-19  Li et al.  Prophylaxis Does physical activity reduce risk for COVID-19? Retrospective study in the United Kingdom Lower severe cases with higher activity levels (p=0.02) c19early.org Li et al., BMC Medical Genomics, February 2021 Favors exercise Favors inactivity

Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study

Li et al., BMC Medical Genomics, doi:10.1186/s12920-021-00887-1
Feb 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Exercise for COVID-19
9th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 66 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Mendelian randomization study showing lower risk of severe COVID-19 with physical activity.
risk of severe case, 81.0% lower, OR 0.19, p = 0.02, RR approximated with OR.
risk of hospitalization, 56.0% lower, OR 0.44, p = 0.07, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Li et al., 3 Feb 2021, retrospective, United Kingdom, peer-reviewed, 2 authors, per SD increase. Contact: shuai.li@unimelb.edu.au (corresponding author).
This PaperExerciseAll
Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study
Shuai Li, Xinyang Hua
BMC Medical Genomics, doi:10.1186/s12920-021-00887-1
Background: Lifestyle factors including obesity and smoking are suggested to be correlated with increased risk of COVID-19 severe illness or related death. However, whether these relationships are causal is not well known; neither for the relationships between COVID-19 severe illness and other common lifestyle factors, such as physical activity and alcohol consumption. Methods: Genome-wide significant genetic variants associated with body mass index (BMI), lifetime smoking, physical activity and alcohol consumption identified by large-scale genome-wide association studies (GWAS) of up to 941,280 individuals were selected as instrumental variables. Summary statistics of the genetic variants on severe illness of COVID-19 were obtained from GWAS analyses of up to 6492 cases and 1,012,809 controls. Two-sample Mendelian randomisation analyses were conducted. Results: Both per-standard deviation (SD) increase in genetically predicted BMI and lifetime smoking were associated with about two-fold increased risks of severe respiratory COVID-19 and COVID-19 hospitalization (all P < 0.05). Per-SD increase in genetically predicted physical activity was associated with decreased risks of severe respiratory COVID-19 (odds ratio [OR] = 0.19; 95% confidence interval [CI], 0.05, 0.74; P = 0.02), but not with COVID-19 hospitalization (OR = 0.44; 95% CI 0.18, 1.07; P = 0.07). No evidence of association was found for genetically predicted alcohol consumption. Similar results were found across robust Mendelian randomisation methods. Conclusions: Evidence is found that BMI and smoking causally increase and physical activity might causally decrease the risk of COVID-19 severe illness. This study highlights the importance of maintaining a healthy lifestyle in protecting from COVID-19 severe illness and its public health value in fighting against COVID-19 pandemic.
Supplementary Information The online version contains supplementary material available at https ://doi. org/10.1186/s1292 0-021-00887 -1. Additional file 1: Supplementary Tables 1-4 . Summary statistics for genetic instrumental variables of the four lifestyle factors. Additional file 2: Supplementary Table 5 . Parameter values used in statistical power analysis. Additional file 3: Supplementary Table 6 . Sample sizes of participating studies in the COVID-19 Host Genetic Initiative GWAS Release 4 in September 2020. Additional file 4: Supplementary Fig. 1 . Leave-one-out analysis results for body mass index and severe respiratory COVID-19. Additional file 5: Supplementary Fig. 2 . Leave-one-out analysis results for body mass index and COVID-19 hospitalization. Additional file 6: Supplementary Fig. 3 . Leave-one-out analysis results for lifetime smoking and severe respiratory COVID-19. Additional file 7: Supplementary Fig. 4 . Leave-one-out analysis results for lifetime smoking and COVID-19 hospitalization. Additional file 8: Supplementary Fig. 5 . Leave-one-out analysis results for physical activity and severe respiratory COVID-19. Additional file 9: Supplementary Fig. 6 . Leave-one-out analysis results for physical activity and COVID-19 hospitalization. Additional file 10: Supplementary Fig. 7 . Leave-one-out analysis results for alcohol consumption and severe respiratory COVID-19 using all genetic variants. Additional file 11: Supplementary Fig. 8 . Leave-one-out..
References
Bowden, Smith, Burgess, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression, Int J Epidemiol
Bowden, Smith, Haycock, Burgess, Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator, Genet Epidemiol
Burgess, Butterworth, Thompson, Mendelian randomization analysis with multiple genetic variants using summarized data, Genet Epidemiol
Burgess, Davies, Thompson, Bias due to participant overlap in two-sample Mendelian randomization, Genet Epidemiol
Burgess, Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome, Int J Epidemiol
Docherty, Harrison, Green, Hardwick, Pius et al., clinical characterisation protocol
Doherty, Smith-Byrne, Ferreira, Holmes, Holmes et al., GWAS identifies 14 loci for device-measured physical activity and sleep duration, Nat Commun
Ellinghaus, Degenhardt, Bujanda, Buti, Albillos et al., Genomewide association study of severe covid-19 with respiratory failure, N Engl J Med
García, Immune response, inflammation, and the clinical spectrum of COVID-19, Front Immunol
Guan, Ni, Hu, Liang, Ou et al., Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med
Hartwig, Smith, Bowden, Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption, Int J Epidemiol
Hemani, Zheng, Elsworth, Wade, Haberland et al., The MR-Base platform supports systematic causal inference across the human phenome, Elife
Leong, Cole, Brenner, Meigs, Florez et al., Cardiometabolic risk factors for COVID-19 susceptibility and severity: a mendelian randomization analysis, medRxiv
Liu, Jiang, Wedow, Li, Brazel et al., Association studies of up to 12 million individuals yield new insights into the genetic etiology of tobacco and alcohol use, Nat Genet
Pierce, Burgess, Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators, Am J Epidemiol
Ponsford, Gkatzionis, Walker, Grant, Wootton et al., Cardiometabolic traits, sepsis and severe COVID-19: a mendelian randomization investigation
Rocha, Libby, Obesity, inflammation, and atherosclerosis, Nat Rev Cardiol
Rossato, Russo, Mazzocut, Vincenzo, Fioretto et al., Current smoking is not associated with COVID-19, Eur Respir J
Simonnet, Chetboun, Poissy, Raverdy, Noulette et al., High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity (Silver Spring)
Simons, Shahab, Brown, Perski, evidence review with Bayesian meta-analyses (version 7)
Smith, Ebrahim, Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol
Tilg, Moschen, Adipocytokines: mediators linking adipose tissue, inflammation and immunity, Nat Rev Immunol
Williamson, Walker, Bhaskaran, Bacon, Bates et al., Factors associated with COVID-19-related death using OpenSAFELY, Nature
Wootton, Richmond, Stuijfzand, Lawn, Sallis et al., Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study, Psychol Med
Yengo, Sidorenko, Kemper, Zheng, Wood et al., Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry, Hum Mol Genet
Ying, Fu, Lee, Olefsky, The role of macrophages in obesityassociated islet inflammation and β-cell abnormalities, Nat Rev Endocrinol
Zhang, Li, Sun, He, Xu et al., Physical activity, BMI and COVID-19: an observational and Mendelian randomisation study, medRxiv
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit